---
title: "TGFB1"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Information about Gene TGFB1"
tags: ['TGFB1', 'TransformingGrowthFactorBeta1', 'Cancer', 'Fibrosis', 'AutoimmuneDisorders', 'DrugResponse', 'Prognosis', 'GeneticInformationAnalysis']
---

## Information about Gene TGFB1

### Genetic Position, Pathology, and Function

- **Genetic Position:** TGFB1 is located on chromosome 19q13.2.
- **Pathology:** The gene is associated with various diseases, including cancers, fibrosis, and autoimmune disorders.
- **Function:** The TGFB1 gene encodes the transforming growth factor beta 1 protein, which is involved in regulating cell growth, proliferation, and differentiation, as well as immune function.

### External IDs, Aliases, and Genomic Location

- **External IDs:** HGNC:11766, NCBI Entrez Gene: 7040, Ensembl: ENSG00000105329, OMIM: 190180, UniProtKB/Swiss-Prot: P01137.
- **Aliases:** TGF-beta 1, CED, TGFB, LAP.
- **Genomic Location:** Chromosome 19q13.2.

### AA Mutation List and Mutation Type with dbSNP ID

- p.Arg25Pro (rs1800470)
- p.Leu10Pro (rs1800471)
- p.Ser33Phe (rs11466323)
- p.Asn78Lys (rs1800472)

### Somatic SNVs/InDels with dbSNP ID

- c.74G>A (rs1800469)
- c.*2T>C (rs1800463)
- c.202A>G (rs1800473)

### Related Disease

- **Cancer:** TGFB1 is associated with various types of cancer, including breast, lung, and pancreatic cancer.
- **Fibrosis:** The gene is involved in the development of fibrosis in various organs, including the lung and liver.
- **Autoimmune Disorders:** TGFB1 is involved in regulating immune function and is associated with autoimmune disorders such as systemic lupus erythematosus and rheumatoid arthritis.

### Treatment and Prognosis

- *Treatment:* Therapeutic targeting of TGFB1 is being investigated for various diseases, including cancer and fibrosis.
- *Prognosis:* The expression of TGFB1 in tumors is associated with poor prognosis in various types of cancer.

### Drug Response

- Various drugs targeting TGFB1, such as anti-TGFB1 monoclonal antibodies and small-molecule inhibitors, are in development or clinical trials for the treatment of cancer, fibrosis, and other diseases.

### Related Papers

- **Subject:** Transforming Growth Factor Beta 1
- **Author:** Roberts AB, Wakefield LM
- **DOI Links:** 
  - 10.1016/B978-012369441-5/50009-6 
  - 10.1146/annurev.cb.13.110197.003543 
  - 10.1038/cr.2015.155

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**